Bryan Williams

Bryan Williams

Director/Board Member chez PACIFIC EDGE LIMITED

Fortune : 31 031 $ au 31/03/2024

74 ans
Consumer Services
Health Technology
Commercial Services

Profil

Bryan Raymond George Williams is currently the Chief Executive Officer & Director at MIMR-PHI Institute of Medical Research and the Chairman at BioGrid Australia Ltd.
He is also an Independent Non-Executive Director at Pacific Edge Ltd.
and a Director at Cancer Trials Australia, Hudson Institute of Medical Research, Pacific Edge Diagnostics Singapore Pte Ltd., Xynapse Therapeutics Pty Ltd., and Cartherics Pty Ltd.
Previously, he served as the Chief Executive Officer & Director at Hudson Institute of Medical Research, Non-Executive Chairman at MEI Pharma, Inc., and Chairman-Department of Cancer Biology at Cleveland Clinic Lerner Research Institute and The Cleveland Clinic Foundation.
He was also the Global Director-Organizational Effectiveness at The Ritz-Carlton Hotel Co. LLC.
Additionally, he served as the Director at Monash Institute of Medical Research and Pacific Edge Pty Ltd.
He has also held positions as a Professor-Department of Genetics at Case Western Reserve University and an Adjunct Professor at Cleveland State University and Kent State University (Ohio).
Dr. Williams received his undergraduate and doctorate degrees from the University of Otago.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/08/2023 610 357 ( 0,08% ) 31 031 $ 31/03/2024

Postes actifs de Bryan Williams

SociétésPosteDébut
PACIFIC EDGE LIMITED Director/Board Member 04/07/2013
Cancer Trials Australia Director/Board Member -
Cartherics Pty Ltd. Director/Board Member -
Xynapse Therapeutics Pty Ltd. Director/Board Member -
Pacific Edge Diagnostics Singapore Pte Ltd. Director/Board Member -
BioGrid Australia Ltd. Chairman -
MIMR-PHI Institute of Medical Research Chief Executive Officer -
Director/Board Member -
Tous les postes actifs de Bryan Williams

Anciens postes connus de Bryan Williams

SociétésPosteFin
Chief Executive Officer 01/01/2017
░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Bryan Williams

Formation de Bryan Williams

University of Otago Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Bryan Williams

Relations

99

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
PACIFIC EDGE LIMITED

Health Technology

MEI PHARMA, INC.

Health Technology

Entreprise privées12

Consumer Services

Commercial Services

Health Services

Cancer Trials Australia

Monash Institute of Medical Research

Pacific Edge Pty Ltd.

MIMR-PHI Institute of Medical Research

BioGrid Australia Ltd.

Commercial Services

Pacific Edge Diagnostics Singapore Pte Ltd.

Xynapse Therapeutics Pty Ltd.

Cartherics Pty Ltd.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Bryan Williams